DK3452019T3 - Anvendelse af sukkeralkoholer i tibolonsammensætninger - Google Patents

Anvendelse af sukkeralkoholer i tibolonsammensætninger Download PDF

Info

Publication number
DK3452019T3
DK3452019T3 DK17723960.5T DK17723960T DK3452019T3 DK 3452019 T3 DK3452019 T3 DK 3452019T3 DK 17723960 T DK17723960 T DK 17723960T DK 3452019 T3 DK3452019 T3 DK 3452019T3
Authority
DK
Denmark
Prior art keywords
tibolon
compositions
sugar alcohols
sugar
alcohols
Prior art date
Application number
DK17723960.5T
Other languages
English (en)
Inventor
Séverine Jaspart
Original Assignee
Novalon S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novalon S A filed Critical Novalon S A
Application granted granted Critical
Publication of DK3452019T3 publication Critical patent/DK3452019T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK17723960.5T 2016-05-04 2017-05-04 Anvendelse af sukkeralkoholer i tibolonsammensætninger DK3452019T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16168390 2016-05-04
PCT/EP2017/060676 WO2017191266A1 (en) 2016-05-04 2017-05-04 Use of sugar-alcohols in tibolone compositions

Publications (1)

Publication Number Publication Date
DK3452019T3 true DK3452019T3 (da) 2021-09-06

Family

ID=55919671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17723960.5T DK3452019T3 (da) 2016-05-04 2017-05-04 Anvendelse af sukkeralkoholer i tibolonsammensætninger

Country Status (15)

Country Link
US (1) US10736907B2 (da)
EP (1) EP3452019B1 (da)
AU (1) AU2017260799B2 (da)
BR (1) BR112018072371B1 (da)
CA (1) CA2970655A1 (da)
CY (1) CY1124392T1 (da)
DK (1) DK3452019T3 (da)
ES (1) ES2889598T3 (da)
HU (1) HUE055164T2 (da)
MX (1) MX381207B (da)
PL (1) PL3452019T3 (da)
PT (1) PT3452019T (da)
SM (1) SMT202100536T1 (da)
WO (1) WO2017191266A1 (da)
ZA (1) ZA201807210B (da)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (da) 1964-06-16
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
ATE364619T1 (de) 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen
TW200418525A (en) 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
EP1563833B1 (de) * 2004-02-06 2006-11-02 Helm AG Pharmazeutische Zubereitungen mit amorphem Tibolon
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
CZ300465B6 (cs) 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
JP6775155B2 (ja) 2015-09-14 2020-10-28 日本新薬株式会社 錠剤

Also Published As

Publication number Publication date
WO2017191266A1 (en) 2017-11-09
ZA201807210B (en) 2022-04-28
PL3452019T3 (pl) 2021-12-20
HUE055164T2 (hu) 2021-11-29
BR112018072371A2 (pt) 2019-02-19
EP3452019B1 (en) 2021-06-23
US20190134058A1 (en) 2019-05-09
BR112018072371B1 (pt) 2024-04-30
PT3452019T (pt) 2021-07-28
AU2017260799A1 (en) 2018-12-13
MX381207B (es) 2025-03-12
AU2017260799B2 (en) 2022-11-24
ES2889598T3 (es) 2022-01-12
SMT202100536T1 (it) 2021-11-12
MX2018013274A (es) 2019-03-06
EP3452019A1 (en) 2019-03-13
CY1124392T1 (el) 2022-07-22
US10736907B2 (en) 2020-08-11
CA2970655A1 (en) 2017-11-04

Similar Documents

Publication Publication Date Title
EP3534968A4 (en) ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS
DK3490582T3 (da) Sammensætninger til anvendelse i behandling af myelofibrose
KR20180084891A (ko) 구조 조성물 및 방법
DK3472317T3 (da) Sammensætninger og fremgangsmåder til reduktion af okulær vaskularisation
CL2016002416A1 (es) Composiciones estables de yodo no en complejo y métodos de uso
EP3344400A4 (en) Three dimensional microtissue bioprinter
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
EP3337502A4 (en) STABLE ANTI-IFNAR1 FORMULATION
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
IL255307B (en) Tpp1 formulations and uses thereon in cln2 disease
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3182962T3 (da) Compositions and uses of amidine derivatives
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3220891T3 (da) Sublingual formulering af riluzol
DK3166911T3 (da) Inkorporering af biologiske midler i gødning
DK3294532T3 (da) Forbedringer i forbindelse med fremstilling af vindmøllekomponenter
DK3474822T3 (da) Formuleringer af brincidofovir
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
DK3204038T3 (da) Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
EP3554470A4 (en) COSMETIC COMPOSITIONS
IL264445A (en) Compounds and compositions and uses thereof
DK3678644T3 (da) Formuleringer af copanlisib
DK3528791T3 (da) Dispergible sammensætninger